Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
How did MoneyWorks4me help subscribers to buy Persistent Systems at Rs. 700/ share in Jan 2020?
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Span Divergent Ltd Stock Analysis

Small Cap
Evaluated by 135 users | BSE: 524727 | NSE: |
Chemicals

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Capital Employed 15.31%1.68%5.92%-2.57%7.37%-3.5%-4.86%-6.23%-3.77%-0.93%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 83.75878.277.872.902.41.71.71.70
Y-o-Y Gr. Rt.--30.7%34.8%-0.5%-6.4%-100%NA-28.9%1.8%-1.2%-
Adjusted EPS (Rs.) 6.28-1.251.32-6.481.88-3.5-5.08-7.53-3.86-1.1-0.09
Y-o-Y Gr. Rt.--119.9%NA-590.9%NA-286.2%NANANANA-
Book Value per Share (Rs.) 37.338.9839.6932.6380.892.5292.4486.880.7280.0581.06
Adjusted Net Profit 4.6-0.91-4.71.4-1.9-2.8-4.1-2.1-0.60
Net Op. Cash Flow (Rs. Cr.) 18.3-1.58.7945-4.1-0.92.4-1.11.1-
Debt to Cash Flow from Ops 1.02-19.264.214.1700-9.114.02-3.832.23-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Span Divergent Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales -35.1%-52.8%-10.6%-1.2%
Adjusted EPS -182.4%-189.8%NANA
Book Value per Share 8.9-0.2-4.7-0.8
Share Price -9% -24.8% -22.8% 43.1%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Equity (%) 18.25-3.273.36-17.933.31-3.5-5.5-8.4-4.61-1.37-0.11
Operating Profit Margin (%) 13.936.59.655.842.070-175.9-252.87-71.84-17.360
Net Profit Margin (%) 5.45-1.571.23-6.061.880-116.43-242.49-121.93-35.170
Debt to Equity 0.690.991.271.58000.170.210.10.06-
Working Capital Days 14920317918711701,2911,027289532-
Cash Conversion Cycle 77126114117570-1244933-
Loading price chart...
Entity Percentage Holding
Promoters 64.13%
Non-Institutions 35.87%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Span Divergent Ltd's earnings have declined by -189.8%, whereas share price has declined -24.8% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.

Span Divergent Ltd share price has declined -9% annually (CAGR) over the past ten years.

Data is not available for this company.

A thought, conceived more than three decades ago by a pathologist, Dr. Pradip K. Desai, evolved into a start-up company as the Desai Laboratories. The goal was to indigenously develop and manufacture a comprehensive range of ready-made diagnostic reagents needed by clinical pathology laboratories. In 1976, the company was reorganized as Span Diagnostics with an emphasis on in-house R & D to develop more and more products, keeping the customer needs in focus and quality under constant
A thought, conceived more than three decades ago by a pathologist, Dr. Pradip K. Desai, evolved into a start-up company as the Desai Laboratories. The goal was to indigenously develop and manufacture a comprehensive range of ready-made diagnostic reagents needed by clinical pathology laboratories. In 1976, the company was reorganized as Span Diagnostics with an emphasis on in-house R & D to develop more and more products, keeping the customer needs in focus and quality under constant vigil. 

The initial efforts yielded success and SPAN became a private limited company in 1981.The company went public in 1994,to bring in more resources and expand further Concurrently , Span Diagnostics Ltd. with a strengthened marketing & distribution network, emerged as a leader in Indian diagnostic market. 

Today, SPAN – a legendary name in the industry is reckoned for its wide range of quality products and dedicated services. The company operates through strategic marketing divisions, ensuring focused approach to specific customer segments. 

Span Diagnostics Ltd. is a pioneer and trend setter of high quality products for pathology & clinical laboratories in the Indian diagnostics industry. A globally acknowledged and fastest growing diagnostic company with a successful track record of over 3 decades having Asia's one of the largest state-of-the-art ISO-9001:2000, WHO cGMP accredited advanced manufacturing facilities with ISO 13485 & CE accredited products. We have our marketing activities across India and 68 countries worldwide. SPAN services end users and distributors with ready to use testing kits and customized OEM products.

SPAN has nurtured its growth by consistently adding new products through R & D endeavors. The products are manufactured at its state-of-the-art plants in India and France , observing WHO-   cGMP norms. 

SPAN also takes pride in having exclusive strategic business alliances with the leading diagnostic companies from world over, to market their products in India. 

Product range of the company includes
  • Diagnostic Reagents & Kits
  • Instruments
  • Industrial & Research Products
  • Veterinary Products
Milestones:
  • 2006 :  Started marketing and distribution office in UAE 
  •            Accredited for ISO 13485 : 2003 
  • 2005 :  Established manufacturing and R&D facility in France 
  • 2004 :  CE Registration 
  •             Started Amesos:Critical Care Product Division 
  •             Introduced IBD:Institutional Business Division. 
  • 2003:  Accredited for ISO 9001:2000 
  •            Formed iD-Serve:Technical support Division for lab automation 
  • 2002 :  Launched Cogent : Clinical Chemistry Division. 
  • 2001 : Initiated international marketing. 
  • 2000 :  Accredited for ISO 9002 and WHO cGMP. 
  •             Formed Strategic marketing Divisions 
  •             PDP : Popular Diagnostic Product Division. 
  •             Stimulus : Speciality Diagnostic Division. 
  •  1998 : Started SPAN iD : Independent Lab Automation Division. 
  •  1994 : Listed at stock exchange. 
  •  1992 : Commissioned modern manufacturing facility. 
  •  1991 : Ventured into lab automation. 
  •  1988 : Established distribution network. 
  •  1982 : Expanded manufacturing facility 
  •  1980 :  Reorganised as Span Diagnostics Pvt. Ltd. 
  •  1976 :  Foundation - Span Diagnostics . 
  •  1972 :  The beginning - Desai Laboratories. 
Achievements/ recognition:
  • ISO 13485:2003 
  • ISO 9001:2000

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback